alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 32.2

Certification of the Chief Financial Officer

Pursuant to 18 U.S.C. Section 1350

As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the Quarterly Report of NPC International, Inc. (the Company) on Form 10-Q for the period ended March 27, 2007 as filed with the
Securities and Exchange Commission on the date hereof (the Report), I, Troy D. Cook, Executive Vice-President - Finance, Chief Financial Officer, Secretary and Treasurer of NPC International, Inc., certify, pursuant to 18 U.S.C. §
1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:



| | (1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
| | --- | ---------------------------------------------------------------------------------------------------------------------



| | (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| | --- | ----------------------------------------------------------------------------------------------------------------------------------------------------

Date: May 11, 2007



/s/ Troy D. CookTroy D. CookExecutive Vice-PresidentFinance, Chief Financial Officer, Secretary and Treasurer


A signed original of this written statement required by Section 906, or other
document authenticating, acknowledging, or

otherwise adopting the signature that appears in typed form within the electronic version
of this written statement required

by Section 906, has been provided to the Company and will be retained by the Company and
furnished to the Securities and

Exchange Commission or its staff upon request.
II 

112TH CONGRESS 

2D SESSION S. 2609 

To extend the temporary suspension of duty on Famoxadone, Cymoxanil, 

and application adjuvants. 

IN THE SENATE OF THE UNITED STATES 

MAY 7, 2012 

Mr. COONS introduced the following bill; which was read twice and referred 

to the Committee on Finance 

A BILL 

To extend the temporary suspension of duty on Famoxadone, 

Cymoxanil, and application adjuvants. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. FAMOXADONE, CYMOXANIL, AND APPLICATION 

4 ADJUVANTS. 

5 (a) IN GENERAL.—Heading 9902.12.45 of the Har6 monized Tariff Schedule of the United States (relating to 

7 mixtures of 5-methyl-5-(4-phenoxyphenyl)–3-(phenyl8 amino)–2,4-oxazolidinedione](famoxadone), 2-cyano-N9 [(ethylamino)-carbonyl]-2-(methoxyimino)acetamide 

10 (Cymoxanil) and application adjuvants) is amended by 


jbell on DSK7SPTVN1PROD with BILLS
2 

•S 2609 IS

1 striking the date in the effective period column and insert2 ing ‘‘12/31/2015’’. 

3 (b) EFFECTIVE DATE.—The amendment made by 

4 subsection (a) applies with respect to goods entered, or 

5 withdrawn from warehouse for consumption, on or after 

6 the 15th day after the date of the enactment of this Act. 

Æ 


jbell on DSK7SPTVN1PROD with BILLS
**Exhibit 23** **Consent    of Independent Registered Pubic Accounting Firm**     The Board of Directors    First Business Financial Services, Inc.:     We consent to the incorporation by reference in the registration    statements    (No. 333-129059,No. 333-137634    and    No. 333-137635)    on    Form S-8    of First Business Financial Services, Inc. and subsidiaries of    our report dated March 17, 2008, with respect to the    consolidated balance sheets of First Business Financial    Services, Inc. and subsidiaries as of December 31, 2007 and    2006, and the related consolidated statements of income, changes    in stockholders’ equity and comprehensive income, and cash    flows for each of the years in the two-year period ended    December 31, 2007, which report appears in the    December 31, 2007, annual report on    Form 10-K    of First Business Financial Services, Inc. /s/  KPMG    LLP     Milwaukee, Wisconsin    March 17, 2008
exv10w13



 







    EXHIBIT 10.13



 




    Indemnification
    Agreements



 



    The following current directors and officers are parties to
    indemnification agreements with
    K-Tron
    International, Inc.:



 



    Kevin C. Bowen




    Edward B. Cloues, II




    Norman Cohen




    Robert A. Engel




    Edward T. Hurd




    Lukas Guenthardt




    Richard J. Pinola




    Ronald R. Remick




    Alan R. Sukoneck
UNPUBLISHED UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT
No. 97-6926
JEFFREY T. BURNS, Plaintiff - Appellant, versus MRS. BLOUNT, Defendant - Appellee, and RONALD AVERY; LIEUTENANT BA TTLE; SERGEANT BEASLEY; OFFICER JACOBS; OFFICER KRULL, Defendants.Appeal from the United States District Court for the Eastern District of North Carolina, at Raleigh. James C. Fox, Chief District Judge. (CA-95-58-5-F) Submitted: September 11, 1997 Decided: September 23, 1997 Before RUSSELL, MURNAGHAN, and HAMILTON, Circuit Judges. Affirmed by unpublished per curiam opinion. Jeffrey T. Burns, Appellant Pro Se. Reid Russell, PATTERSON, DILTHEY, CLAY & BRYSON, Raleigh, North Carolina, for Appellee.2 Unpublished opinions are not binding precedent in this circuit. See Local Rule 36(c).

PER CURIAM: Appellant appeals the district court's order denying relief on his 42 U.S.C. § 1983 (1994) complaint. We have reviewed the recordand the district court's opinions partially accepting the magistrate judge's recommendation and find no reversible error. Accordingly, we affirm on the reasoning of the district court. Burns v. Blount , No. CA-95-58-5-F (E.D.N.C. Aug. 14, 1996 & June 17, 1997).We dispense with oral argument because the facts and legal contentions are adequately presented in the materials before the court and argument would not aid the decisional process.

AFFIRMED
UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

No. 03-6714

CHARLES M. CASSELL, III,

Plaintiff - Appellant,

 and

THOMAS J. SHIELDS,

Plaintiff,

versus

SARGEANT NORRIS; LIEUTENANT ONEAL; CAPTAIN

WHELMAN; NURSE HART,

Defendants - Appellees.

Appeal from the United States District Court for the Eastern

District of North Carolina, at Raleigh. Malcolm J. Howard, District

Judge. (CA-02-943-5-H)

Submitted: November 7, 2003 Decided: December 23, 2003

Before TRAXLER and GREGORY, Circuit Judges, and HAMILTON, Senior

Circuit Judge.

Affirmed by unpublished per curiam opinion.

Charles M. Cassell, III, Appellant Pro Se. 
2

Unpublished opinions are not binding precedent in this circuit.

See Local Rule 36(c).

PER CURIAM:

Charles M. Cassell, III, appeals the district court’s order

denying relief on his 42 U.S.C. § 1983 (2000) complaint. We have

reviewed the record and find no reversible error. Accordingly, we

affirm for the reasons stated by the district court. See Cassell

v. Sargeant Norris, No. CA-02-943-5-H (E.D.N.C. filed Apr. 18, 2003

& entered Apr. 21, 2003). We also deny all of Cassell’s pending

motions. We dispense with oral argument because the facts and legal

contentions are adequately presented in the materials before the

court and argument would not aid the decisional process.

AFFIRMED
Exhibit 32.2  SECTION 906 CERTIFICATION  CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002  In connection with the quarterly report of Medizone International, Inc. (the Company) on Form 10-Q for the quarter ended September 30, 2009, as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Steve M. Hanni, Principal Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge and belief:  (1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and  (2) the information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.   /s/ Steve M. Hanni Steve M. Hanni, Principal Financial Officer  Date: November 10, 2009  A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.  This certification accompanies each Report pursuant to § 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of §18 of the Securities Exchange Act of 1934, as amended.
<PAGE>1

                                                           EXHIBIT 32.1

                                  CERTIFICATION

This certification is provided pursuant to Section 906 of the Sarbanes-Oxley Act
of 2002 and accompanies the quarterly report on Form 10-Q (the "Form 10-Q") for
the quarter ended September 30, 2004 of American Insured Mortgage Investors -
Series 85, L.P. (the "Issuer").

I, Barry S. Blattman, Chairman of the Board and Chief Executive Officer, certify
that to the best of my knowledge:

  (i)     the Form 10-Q fully complies with the requirements of section 13(a) or
          section 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m(a)
          or 78o(d)); and

  (ii)    the information contained in the Form 10-Q fairly represents, in
          all material respects, the financial condition and results of
          operations of the Issuer.


                                                    AMERICAN INSURED MORTGAGE
                                                    INVESTORS - SERIES 85, L.P.
                                                    (Registrant)

                                                    By:      CRIIMI, Inc.
                                                             General Partner



November 9, 2004                                    /s/Barry S. Blattman
----------------                                    -------------------------
Date                                                Barry S. Blattman
                                                    Chairman of the Board and
                                                    Chief Executive Officer


A signed original of this written statement required by Section 906 has been
provided to the General Partner and will be retained by the General Partner and
furnished to the Securities and Exchange Commission or its staff upon request.
# **EXHIBIT 32.2**

**CERTIFICATION**

*Pursuant to 18 U.S.C. Section 1350, As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002*

In connection with the Annual Report of Riverbend Holdings, Inc. (the “Company”) on Form 10-KSB for the year ended December 31, 2004 as filed with the Securities and Exchange Commission on the date hereof (the“Report), Leon Nowalsky, as Principal Financial and Accounting Officer of the Company hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to the best of his knowledge, that:

| (1)    | the Report fully complies with the requirements of section 13(a) of the Securities Exchange Act of 1934; and                                         |
|-----------------------|------------------------------------------------------------------------------------------------------------------------------------------------------|
|                       |                                                                                                                             |
| (2)    | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |

/s/ Leon Nowalsky                   Leon NowalskyTreasurer (Principal Financial Officer)Date:  April 13, 2005This certification accompanies this Report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.
II 

112TH CONGRESS 

2D SESSION S. 2680 

To suspend temporarily the duty on mixtures containing fluopyram and 

tebuconazole. 

IN THE SENATE OF THE UNITED STATES 

MAY 7, 2012 

Mr. CASEY introduced the following bill; which was read twice and referred 

to the Committee on Finance 

A BILL 

To suspend temporarily the duty on mixtures containing 

fluopyram and tebuconazole. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. MIXTURES CONTAINING FLUOPYRAM AND 

4 TEBUCONAZOLE. 

5 (a) IN GENERAL.—Subchapter II of chapter 99 of 

6 the Harmonized Tariff Schedule of the United States is 

7 amended by inserting in numerical sequence the following 

8 new heading: 


rfrederick on DSK6VPTVN1PROD with BILLS
2 

•S 2680 IS

‘‘ 9902.01.00 Mixtures containing N-{2-[3- 

chloro-5-(trifluoromethyl)-2- 

pyridinyl]ethyl}-α,α,αtrifluoro-o-toluamide 

(fluopyram) (CAS No. 

658066–35–4) and (RS)-1-pchlorophenyl)-4,4-dimethyl-3- 

(1H-1,2,4-triazol-1- 

ylmethyl)pentan-3-ol 

(tebuconazole) (CAS No. 

107534–96–3), including application adjuvants (provided 

for in subheading 

3808.91.50) ........................... Free No change No change On or before 

12/31/2015 ’’. 

1 (b) EFFECTIVE DATE.—The amendment made by 

2 subsection (a) applies with respect to goods entered, or 

3 withdrawn from warehouse for consumption, on or after 

4 the 15th day after the date of the enactment of this Act. 

Æ 


rfrederick on DSK6VPTVN1PROD with BILLS
**Exhibit 31.2**

 

**CERTIFICATIONS**

 

I, Lori A. Jones, certify that: 

 

1. I have reviewed this quarterly report on Form 10-Q of Analytical Surveys, Inc.; 

 

2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state amaterial fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report; 

 

3. Based on my knowledge, the financial statements, and other financialinformation included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report; 

 

4. The registrant’s other certifying officer(s) and I are responsiblefor establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and the registrant’s have: 

 

a) Designed such disclosure controls and procedures, or caused such disclosure control and procedures to be designed underour supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is beingprepared; 

 

b) Evaluated the effectiveness of theregistrant’s disclosure controls and procedures and presented in this quarterly report our conclusions about the effectiveness of the disclosure control and procedures as of the end of the period covered by this quarterly report based on suchevaluation; and 

 

c) Disclosed in this quarterly report anychange in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materiallyaffected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recentevaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): 

 

a) All significant deficiencies and material weaknesses in the design oroperation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and 

 

b) Any fraud, whether or not material, that involves management or otheremployees who have a significant role in the registrant’s internal control over financial reporting. 

 

Date: May 17, 2004 

 

/s/ Lori A. Jones 

Lori A. Jones 

Chief Financial Officer
```

[Congressional Bills 112th Congress]
[From the U.S. Government Publishing Office]
[S. 285 Reported in House (RH)]

                                                 Private Calendar No. 7
112th CONGRESS
  2d Session
                                 S. 285

                          [Report No. 112-695]

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                             July 26, 2012

               Referred to the Committee on the Judiciary

                           November 15, 2012

       Referred to the Private Calendar and ordered to be printed

_______________________________________________________________________

                                 AN ACT

 
                 For the relief of Sopuruchi Chukwueke.

 

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. ADJUSTMENT OF STATUS.

    (a) In General.--Notwithstanding any other provision of law, for 
the purposes of the Immigration and Nationality Act (8 U.S.C. 1101 et 
seq.), Sopuruchi Chukwueke shall be deemed to have been lawfully 
admitted to, and remained in, the United States, and shall be eligible 
for adjustment of status to that of an alien lawfully admitted for 
permanent residence under section 245 of the Immigration and 
Nationality Act (8 U.S.C. 1255) upon filing an application for such 
adjustment of status.
    (b) Application and Payment of Fees.--Subsection (a) shall apply 
only if the application for adjustment of status is filed with 
appropriate fees not later than 2 years after the date of the enactment 
of this Act.
    (c) Reduction of Immigrant Visa Numbers.--Upon the granting of 
permanent resident status to Sopuruchi Chukwueke, the Secretary of 
State shall instruct the proper officer to reduce by 1, during the 
current or next following fiscal year, the total number of immigrant 
visas that are made available to natives of the country of the birth of 
Sopuruchi Chukwueke under section 202(a)(2) of the Immigration and 
Nationality Act (8 U.S.C. 1152(a)(2)).
    (d) Denial of Preferential Immigration Treatment for Certain 
Relatives.--The natural parents, brothers, and sisters of Sopuruchi 
Victor Chukwueke shall not, by virtue of such relationship, be accorded 
any right, privilege, or status under the Immigration and Nationality 
Act (8 U.S.C. 1101 et seq.).
                                                 Private Calendar No. 7

112th CONGRESS

  2d Session

                                 S. 285

                          [Report No. 112-695]

_______________________________________________________________________

                                 AN ACT

                 For the relief of Sopuruchi Chukwueke.

_______________________________________________________________________

                           November 15, 2012

       Referred to the Private Calendar and ordered to be printed
```
**EXHIBIT21.1**

 

**LIST OFSUBSIDIARIES OF HILAND PARTNERS, LP**

** **

** **
| ** **                     | ** ** | **Jurisdiction  of** | ** ** |
|--------------------------------|------------|----------------------|------------|
| **Entity**                     | ** ** | **Organization**     | ** ** |
| Hiland  Operating, LLC         |       | Delaware             |       |
|                           |       |                 |       |
| Hiland  GP, LLC                |       | Delaware             |       |
|                           |       |                 |       |
| Hiland  LP, LLC                |       | Delaware             |       |
|                           |       |                 |       |
| Hiland  Energy Partners, LLC   |       | Delaware             |       |
|                           |       |                 |       |
| Continental  Gas Operating, LP |       | Oklahoma             |       |

 

----
### Summary of Interagency Working Comments on Draft Language under EO12866/13563 Interagency Revi ew. Subject to Further Policy Review.

1 Environmental Protection Agency (EPA): Proposed Rule

Oil and Natural Gas Sector: Emission Standards for New and Modified Sources

RIN 2060

- A S30

General Comments :

1. Reviewer recommends that the EPA solicit comment on whether it should require quarterly monitoring of fugitive emissions for all facilities (well pads, gathering and boosting stations, transmission compressor stations) regardless of percentage of components detect ed as having fugitive emissions.

EPA RESPONSE: EPA agrees and is soliciting comment on the following:

- “We solicit comment on the appropriateness of the percentage of emission reduction level that can be reasonably expected to be achieved with quarterl y, semiannual, and annual monitoring program frequencies.”

- “ We solicit comment on this approach, including the percentage used to adjust the monitoring frequency. We also solicit comment on the appropriateness of performance based monitoring frequencies

. ”

2. Reviewer recommends that EPA solicit comment on whether wells that do hydraulic refracturing should be required to conduct LDAR or be treated as a modified source regardless of whether they do a REC/green completion. Currently, such facilities are ex empt if they conduct a well completion.

EPA RESPONSE: The affected facility status of a “well” for purposes of the well completion requirements is separate from the affected facility status of a “well site” for purposes of the fugitive emissions requirem ents. As a result, modification of a “well” is not the same as modification of a “well site.” In the proposal, well sites are modified through addition of a new well or by fracturing (or refracturing) of an existing well at that site.

3. Reviewer recommends EPA solicit comment whether zero

- bleed pneumatic controllers should be required in segments that have access to electricity.

EPA RESPONSE: EPA agrees with the reviewer and has already incorporated provisions to address this in the proposal. The proposal identifies that a constant reliable electrical supply is necessary to run the compressor for the system. We identify that for the production, transmission, and storage segments electrical service sufficient to power an instru ment air system is likely unavailable (EPA is proposing the installation of low

- bleed pneumatic controllers for these segments)

. However, we are requiring the use of instrument air

- activated controllers in the processing

segment where s ufficient electric s ervice is likely to be available

. Instrument air

- activated

### Summary of Interagency Working Comments on Draft Language under EO12866/13563 Interagency Revi ew. Subject to Further Policy Review.

2 controllers represent an emission rate of zero for methane. Accordingly, we are proposing a methane standard for pneumatic controllers in the processing segment to be a natural gas

bleed rate of ze ro. This is the same as the VOC standard for these pneumatic controllers in

the 2012 NSPS.